Investor Documents
-
February 12, 2025
Investor Presentation
VIEW Presentation -
January 14, 2025
Shareholder Letter
VIEW Letter
Events
-
No upcoming events. Subscribe to receive alerts.
Subscribe Here
Latest Quarterly Results
Q1 2025
Quarter Ended December 31, 2024
OneRF: Highlight of Clara’s successful
After many years of Drug Resistant Epilepsy she has been seizure free for months after OneRF ablation treatment. Hear about her Epilepsy journey and OneRF treatment.
NeuroOne is a medical technology company that is transforming the diagnosis and treatment of neurological disorders
FDA-Cleared
3 FDA 510(k) cleared products for use in the brain, with the only FDA cleared product that uses the same sEEG electrode for both diagnostic and therapeutic applications. Additional submissions planned for 2025.
Patented Technology
Patented and disruptive technology unlocking multi-billion markets in neurology.
Exclusive Partnerships
Patented and disruptive technology unlocking multi-billion markets in neurology.